Alzheimer’s Research in Tennessee – Dr. John Dougherty

Medinteract’s co-founder, Dr. John Dougherty and Dr. Alan Solomon from the University of Tennessee Medical Center, discuss the exciting research collaboration with Eli Lilly and Co. and the newly FDA-approved Amyvid which is used in the early diagnosis of mild cognitive impairment (MCI) and early Alzheimer’s disease.

http://www.knoxnews.com/news/2012/apr/15/doctors-collaborate-on-study-of-early-alzheimers/



Leave a Reply